Published in Am J Pathol on January 01, 1989
RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities. J Cell Biol (1990) 1.44
Coordinate role for cell surface chondroitin sulfate proteoglycan and alpha 4 beta 1 integrin in mediating melanoma cell adhesion to fibronectin. J Cell Biol (1992) 1.25
Recognition of the A chain carboxy-terminal heparin binding region of fibronectin involves multiple sites: two contiguous sequences act independently to promote neural cell adhesion. J Cell Biol (1990) 1.06
Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide. J Cell Biol (1992) 0.99
Endothelial cells support persistent gammaherpesvirus 68 infection. PLoS Pathog (2008) 0.98
Herpes virus infection of endothelium: new insights into atherosclerosis. Trans Am Clin Climatol Assoc (1992) 0.79
Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18
Arg-Gly-Asp: a versatile cell recognition signal. Cell (1986) 7.89
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry (1982) 6.87
Cell surface interactions with extracellular materials. Annu Rev Biochem (1983) 6.76
Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol (1987) 5.69
Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J Cell Biol (1984) 3.18
Endocytosis: relation to capping and cell locomotion. Science (1984) 2.91
Virus-induced atherosclerosis. J Exp Med (1978) 2.32
Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A (1983) 2.26
Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells. J Cell Biol (1986) 1.98
Virus infection of endothelial cells. J Infect Dis (1981) 1.87
Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol (1979) 1.82
Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin, and synthetic peptides. J Cell Biol (1986) 1.62
Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration. J Cell Biol (1988) 1.53
Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry (1988) 1.49
Herpes simplex and varicella-zoster: comparative histopathology of 77 cases. Int J Dermatol (1974) 1.31
Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest (1980) 1.27
Extracellular matrices and cell adhesion. Arteriosclerosis (1985) 1.20
Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J Clin Invest (1987) 1.20
Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients. Exp Mol Pathol (1984) 1.19
Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol (1982) 1.16
Adhesion of endothelial cells to extracellular matrix proteins. J Cell Physiol (1983) 0.99
Herpes simplex virus binding and entry modulate cell surface protein mobility. J Virol (1984) 0.96
Organization of cytoskeleton elements during herpes simplex virus type 1 infection of human fibroblasts: an immunofluorescence study. J Gen Virol (1986) 0.94
Either exogenous or endogenous fibronectin can promote adherence of human endothelial cells. J Cell Sci (1986) 0.91
Endothelial culture, neutrophil or enzymic generation of free radicals: in vitro methods for the study of endothelial injury. Methods Enzymol (1984) 0.82
Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest (1987) 0.82
Herpes simplex virus suppression of human endothelial matrix protein synthesis is independent of viral protein synthesis. Lab Invest (1986) 0.81
Suppression of matrix protein synthesis by herpes simplex virus type 1 in human endothelial cells. Coll Relat Res (1986) 0.80
Loss of surface fibronectin after infection of cultured cells by HSV-1 and 2. Arch Virol (1985) 0.79
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest (1977) 5.16
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest (1977) 4.08
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med (1977) 3.43
Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol (1978) 3.16
Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int (2001) 3.07
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med (1993) 2.90
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
Neurite extension by peripheral and central nervous system neurons in response to substratum-bound fibronectin and laminin. Dev Biol (1983) 2.48
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood (1993) 2.48
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (1980) 2.47
Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol (1995) 2.45
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med (1990) 2.44
Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med (1980) 2.41
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med (1994) 2.36
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol (1999) 2.14
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood (2000) 2.10
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J Cell Biol (1983) 2.07
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother (2001) 2.03
Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. J Clin Invest (1979) 2.01
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99
Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells. J Cell Biol (1986) 1.98
Elevated erythrocyte calcium in sickle cell disease. Nature (1973) 1.97
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol (1984) 1.95
In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis. J Exp Med (1977) 1.94
Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA (1990) 1.82
Plasma exchange in the treatment of immune disease. Transfusion (1976) 1.81
An outbreak of herpes gladiatorum at a high-school wrestling camp. N Engl J Med (1991) 1.80
Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med (1974) 1.80
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood (1980) 1.77
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest (1991) 1.77
Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75
A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell (1993) 1.75
Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest (1991) 1.68
Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science (2000) 1.67
Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation (1999) 1.66
Reperfusion injury pathophysiology in sickle transgenic mice. Blood (2000) 1.65
Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol (1999) 1.65
Effects of sulfhydryl inhibition on red blood cells. 3. Glutathione in the regulation of the hexose monophosphate pathway. J Biol Chem (1966) 1.62
Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med (1981) 1.62
Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med (1971) 1.60
The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J Infect Dis (2000) 1.57
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration. J Cell Biol (1988) 1.53
Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis. Blood (1978) 1.52
Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab Invest (1994) 1.52
Immunological identification of two sulfhydryl-containing fragments of human plasma fibronectin. J Biol Chem (1982) 1.52
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol (2001) 1.51
Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb (1991) 1.49
Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry (1988) 1.49
Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Cancer (1999) 1.49
Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science (1973) 1.49
Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48
Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int (2006) 1.46
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Abnormal haem binding and globin SH group blockade in unstable haemoglobins. Nature (1968) 1.44
Production of laminin and fibronectin by Schwannoma cells: cell-protein interactions in vitro and protein localization in peripheral nerve in vivo. J Cell Biol (1983) 1.44
RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities. J Cell Biol (1990) 1.44
Immunocytochemical localization of fibronectin (LETS proteins) on the surface of L6 myoblasts: light and electron microscopic studies. Cell (1978) 1.42
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell (1983) 1.42
Deleterious effects of endotoxin on cultured endothelial cells: an in vitro model of vascular injury. Inflammation (1981) 1.40
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol (1997) 1.40
Complement-mediated granulocyte dysfunction in paroxysmal nocturnal hemoglobinuria. Blood (1976) 1.37
Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest (1992) 1.36
Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest (1986) 1.36
The role of cell adhesion proteins--laminin and fibronectin--in the movement of malignant and metastatic cells. Cancer Metastasis Rev (1985) 1.36